Bimzelx (bimekizumab-bkzx) — Highmark
Non-radiographic Axial Spondyloarthritis (nr-axSpA)
Initial criteria
- age ≥ 18 years
- diagnosis of non-radiographic axial spondyloarthritis (nr-axSpA)
- prescribed by or in consultation with a rheumatologist
- therapeutic failure or intolerance to at least one step 1 plan-preferred agent for nr-axSpA
Reauthorization criteria
- disease stability or beneficial response to therapy